Literature DB >> 24439205

Chemical biology approaches to designing defined carbohydrate vaccines.

Chakkumkal Anish1, Benjamin Schumann2, Claney Lebev Pereira3, Peter H Seeberger4.   

Abstract

Carbohydrate antigens have shown promise as important targets for developing effective vaccines and pathogen detection strategies. Modifying purified microbial glycans through synthetic routes or completely synthesizing antigenic motifs are attractive options to advance carbohydrate vaccine development. However, limited knowledge on structure-property correlates hampers the discovery of immunoprotective carbohydrate epitopes. Recent advancements in tools for glycan modification, high-throughput screening of biological samples, and 3D structural analysis may facilitate antigen discovery process. This review focuses on advances that accelerate carbohydrate-based vaccine development and various technologies that are driving these efforts. Herein we provide a critical overview of approaches and resources available for rational design of better carbohydrate antigens. Structurally defined and fully synthetic oligosaccharides, designed based on molecular understanding of antigen-antibody interactions, offer a promising alternative for developing future carbohydrate vaccines.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24439205     DOI: 10.1016/j.chembiol.2014.01.002

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  41 in total

Review 1.  Recent advances in the molecular design of synthetic vaccines.

Authors:  Lyn H Jones
Journal:  Nat Chem       Date:  2015-12       Impact factor: 24.427

2.  Improving vaccines against Streptococcus pneumoniae using synthetic glycans.

Authors:  Paulina Kaplonek; Naeem Khan; Katrin Reppe; Benjamin Schumann; Madhu Emmadi; Marilda P Lisboa; Fei-Fei Xu; Adam D J Calow; Sharavathi G Parameswarappa; Martin Witzenrath; Claney L Pereira; Peter H Seeberger
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

Review 3.  Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.

Authors:  Jacqueline M Achkar; Rafael Prados-Rosales
Journal:  Curr Opin Immunol       Date:  2018-04-12       Impact factor: 7.486

4.  A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection.

Authors:  Sharavathi Guddehalli Parameswarappa; Katrin Reppe; Andreas Geissner; Petra Ménová; Subramanian Govindan; Adam D J Calow; Annette Wahlbrink; Markus W Weishaupt; Bopanna Ponnappa Monnanda; Roland Lawrence Bell; Liise-Anne Pirofski; Norbert Suttorp; Leif Erik Sander; Martin Witzenrath; Claney Lebev Pereira; Chakkumkal Anish; Peter H Seeberger
Journal:  Cell Chem Biol       Date:  2016-11-03       Impact factor: 8.116

5.  Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Zhongwu Guo
Journal:  Chem Commun (Camb)       Date:  2015-06-14       Impact factor: 6.222

6.  Brazilian meningococcal C conjugate vaccine: physicochemical, immunological, and thermal stability characteristics.

Authors:  Renata Chagas Bastos; Marilza Batista Corrêa; Iaralice Medeiros de Souza; Milton Neto da Silva; Denise da Silva Gomes Pereira; Fernanda Otaviano Martins; Camila da Silva Faria; Ana Paula Dinis Ano Bom; Maria de Lourdes Leal; Ellen Jessouroun; José Godinho da Silva; Ricardo de Andrade Medronho; Ivna Alana Freitas Brasileiro da Silveira
Journal:  Glycoconj J       Date:  2017-09-19       Impact factor: 2.916

7.  Biomimetic Glyconanoparticle Vaccine for Cancer Immunotherapy.

Authors:  Eliran Moshe Reuven; Shani Leviatan Ben-Arye; Hai Yu; Roberto Duchi; Andrea Perota; Sophie Conchon; Shirley Bachar Abramovitch; Jean-Paul Soulillou; Cesare Galli; Xi Chen; Vered Padler-Karavani
Journal:  ACS Nano       Date:  2019-03-11       Impact factor: 15.881

8.  Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide.

Authors:  Filippo Carboni; Roberto Adamo; Monica Fabbrini; Riccardo De Ricco; Vittorio Cattaneo; Barbara Brogioni; Daniele Veggi; Vittoria Pinto; Irene Passalacqua; Davide Oldrini; Rino Rappuoli; Enrico Malito; Immaculada Y Ros Margarit; Francesco Berti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

9.  6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Jun Liao; Luning Zu; Qiuye Wu; Zhongwu Guo
Journal:  ACS Infect Dis       Date:  2015-12-30       Impact factor: 5.084

10.  A Convergent Synthesis of 6-O-Branched β-Glucan Oligosaccharides.

Authors:  Guochao Liao; Srinivas Burgula; Zhifang Zhou; Zhongwu Guo
Journal:  European J Org Chem       Date:  2015-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.